Advanced search
Publication Cover
Leukemia & Lymphoma Latest Articles
Submit an article Journal homepage
37
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

High red cell mass and high plasma volume are independently associated with thrombotic risk in polycythemia vera

Ivan Krecaka Department of Internal Medicine, General Hospital of Sibenik-Knin County, Sibenik, Croatia;b Faculty of Medicine, University of Rijeka, Rijeka, Croatia;c University of Applied Sciences, Sibenik, CroatiaORCID Iconhttps://orcid.org/0000-0002-8642-305X
ORCID Icon,
Danijela Lekovicd Clinic of Hematology, University Clinical Center of Serbia, Belgrade, Serbia;e Faculty of Medicine, University of Belgrade, Belgrade, SerbiaCorrespondence[email protected]
,
Andrija Bogdanovicd Clinic of Hematology, University Clinical Center of Serbia, Belgrade, Serbia;e Faculty of Medicine, University of Belgrade, Belgrade, Serbia
&
Marko Lucijanicf Division of Hematology, University Hospital Dubrava, Zagreb, Croatia;g School of Medicine, University of Zagreb, Zagreb, CroatiaORCID Iconhttps://orcid.org/0000-0002-1372-2040
ORCID Icon
Received 13 Apr 2024, Accepted 04 Jun 2024, Published online: 20 Jun 2024

References

  • Tefferi A, Vannucchi AM, Passamonti F, et al. Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet. Leukemia. 2018;32(5):1057–1069. doi:10.1038/s41375-018-0077-1
  • Barbui T, Carobbio A, Rumi E, et al. In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology. Blood. 2014;124(19):3021–3023. doi:10.1182/blood-2014-07-591610
  • Pourcelot E, Trocme C, Mondet J, et al. Cytokine profiles in polycythemia vera and essential thrombocythemia patients: clinical implications. Exp Hematol. 2014;42(5):360–368. doi:10.1016/j.exphem.2014.01.006
  • Vaidya R, Gangat N, Jimma T, et al. Plasma cytokines in polycythemia vera: phenotypic correlates, prognostic relevance, and comparison with myelofibrosis. Am J Hematol. 2012;87(11):1003–1005. doi:10.1002/ajh.23295
  • Duchemin J, Ugo V, Ianotto JC, et al. Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms. Thromb Res. 2010;126(3):238–242. doi:10.1016/j.thromres.2010.06.025
  • Duarte K, Monnez JM, Albuisson E, et al. Prognostic Value of Estimated Plasma Volume in Heart Failure. JACC Heart Fail. 2015;3(11):886–893. doi:10.1016/j.jchf.2015.06.014
  • Krečak I, Nižetić K, Čeko M, et al. Higher estimated plasma volume status may be associated with an inferior survival in patients with pulmonary embolism. Int J Lab Hematol. 2023;45(2):e32–e35. doi:10.1111/ijlh.13982
  • Krečak I, Zekanović I, Holik H, et al. Estimating plasma volume using the Strauss-derived formula may improve prognostication in polycythemia vera. Int J Lab Hematol. 2022;44(2):e69–e71. doi:10.1111/ijlh.13716
  • Lucijanic M, Krecak I, Soric E, et al. Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis. Biochem Med (Zagreb). 2023;33(2):020901. doi:10.11613/BM.2023.020901
  • Lucijanic M, Lekovic D, Bogdanovic A, et al. Being John Plasma Volumovich, pecularities of plasma volume estimation in patients with polycythemia vera. Thromb Res. 2024;239:109039. doi:10.1016/j.thromres.2024.109039
  • Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405. doi:10.1182/blood-2016-03-643544
  • Recommended methods for measurement of red-cell and plasma volume: international Committee for Standardization in Haematology. J Nucl Med. 1980;21(8):793–800.
  • Pearson TC, Guthrie DL, Simpson J, et al. Interpretation of measured red cell mass and plasma volume in adults: expert panel on radionuclides of the International Council for Standardization in Haematology. Br J Haematol. 1995;89(4):748–756. doi:10.1111/j.1365-2141.1995.tb08411.x
  • Tefferi A, Loscocco GG, Farrukh F, et al. A globally applicable “triple A“; risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte count. Am J Hematol. 2023;98(12):1829–1837. doi:10.1002/ajh.27079
  • Krecak I, Lekovic D, Arsenovic I, et al. The triple A model (Age, Absolute neutrophil count, Absolute lymphocyte count-AAA) predicts survival and thrombosis in polycythemia vera. Am J Hematol. 2024; 99(5):989-992.
  • Gerds AT, Mesa R, Burke JM, et al. Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL. Blood. 2024;143(16):1646–1655. doi:10.1182/blood.2023020232

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.